US Stock MarketDetailed Quotes

Ekso Bionics (EKSO)

Watchlist
  • 8.550
  • +0.450+5.56%
Close Jan 15 16:00 ET
  • 8.500
  • -0.050-0.58%
Post 19:58 ET
29.01MMarket Cap-1.59P/E (TTM)

Ekso Bionics (EKSO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
2.37%4.23M
-58.44%2.06M
-10.14%3.38M
-1.94%17.93M
5.01%5.09M
-10.38%4.13M
5.25%4.95M
-8.88%3.76M
41.57%18.28M
36.50%4.85M
Operating revenue
2.37%4.23M
-58.66%1.98M
-10.14%3.38M
-5.30%16.97M
-7.84%4.14M
-10.38%4.13M
4.35%4.8M
-8.88%3.76M
50.35%17.92M
75.45%4.49M
Cost of revenue
-12.60%1.68M
-46.48%1.24M
-13.07%1.57M
-8.54%8.41M
-4.12%2.38M
-10.74%1.92M
-5.55%2.31M
-14.94%1.81M
37.35%9.2M
32.30%2.48M
Gross profit
15.39%2.55M
-68.94%819K
-7.43%1.81M
4.76%9.51M
14.56%2.71M
-10.06%2.21M
16.99%2.64M
-2.45%1.95M
46.11%9.08M
41.18%2.37M
Operating expense
-18.50%3.95M
-3.58%4.79M
0.75%5.25M
-17.44%19.97M
-15.02%4.94M
-10.01%4.85M
-23.95%4.97M
-19.25%5.21M
11.12%24.19M
-4.84%5.82M
Selling and administrative expenses
-16.46%3.4M
2.23%3.94M
4.59%4.26M
-16.01%16.1M
-9.01%4.1M
-3.71%4.07M
-24.98%3.86M
-23.10%4.07M
5.63%19.17M
-12.83%4.51M
-Selling and marketing expense
-25.40%1.31M
-8.45%1.69M
-6.11%1.71M
-13.74%7.31M
-4.99%1.88M
-14.23%1.76M
-21.41%1.85M
-12.93%1.82M
18.37%8.47M
1.95%1.98M
-General and administrative expense
-9.65%2.09M
12.04%2.25M
13.23%2.55M
-17.81%8.79M
-12.17%2.22M
6.20%2.31M
-27.98%2.01M
-29.73%2.25M
-2.67%10.69M
-21.75%2.52M
Research and development costs
-29.21%550K
-23.66%852K
-13.03%988K
-22.91%3.87M
-35.64%845K
-32.96%777K
-20.17%1.12M
-1.56%1.14M
38.58%5.03M
38.79%1.31M
Operating profit
46.87%-1.4M
-70.24%-3.98M
-5.65%-3.44M
30.78%-10.46M
35.34%-2.23M
9.96%-2.64M
45.49%-2.34M
26.80%-3.26M
2.85%-15.11M
22.25%-3.45M
Net non-operating interest income expense
77.22%-18K
12.16%-65K
-26.32%-72K
10.93%-269K
10.61%-59K
-23.44%-79K
-21.31%-74K
49.11%-57K
-93.59%-302K
0.00%-66K
Non-operating interest expense
-77.22%18K
-12.16%65K
26.32%72K
-10.93%269K
-10.61%59K
23.44%79K
21.31%74K
-49.11%57K
93.59%302K
0.00%66K
Other net income (expense)
-100.15%-1K
19,114.29%1.33M
635.34%621K
-378.24%-601K
-473.42%-1.12M
274.59%646K
-106.09%-7K
-167.84%-116K
-65.82%216K
-77.27%301K
Gain on sale of security
-99.38%4K
19,228.57%1.34M
640.52%627K
-315.05%-600K
-456.01%-1.13M
273.73%648K
-104.83%-7K
-160.73%-116K
-57.85%279K
-76.68%316K
Other non- operating income (expenses)
-150.00%-5K
---8K
---6K
98.41%-1K
106.67%1K
-166.67%-2K
----
----
-110.00%-63K
51.61%-15K
Income before tax
31.42%-1.42M
-12.13%-2.71M
15.69%-2.89M
25.45%-11.33M
-6.19%-3.41M
38.42%-2.07M
42.88%-2.42M
21.87%-3.43M
-0.78%-15.2M
-1.13%-3.21M
Income tax
Net income
31.42%-1.42M
-12.13%-2.71M
15.69%-2.89M
25.45%-11.33M
-6.19%-3.41M
38.42%-2.07M
42.88%-2.42M
21.87%-3.43M
-0.78%-15.2M
-1.13%-3.21M
Net income continuous Operations
31.42%-1.42M
-12.13%-2.71M
15.69%-2.89M
25.45%-11.33M
-6.19%-3.41M
38.42%-2.07M
42.88%-2.42M
21.87%-3.43M
-0.78%-15.2M
-1.13%-3.21M
Minority interest income
Net income attributable to the parent company
31.42%-1.42M
-12.13%-2.71M
15.69%-2.89M
25.45%-11.33M
-6.19%-3.41M
38.42%-2.07M
42.88%-2.42M
21.87%-3.43M
-0.78%-15.2M
-1.13%-3.21M
Preferred stock dividends
Other preferred stock dividends
226K
0
Net income attributable to common stockholders
31.42%-1.42M
-12.13%-2.71M
9.10%-3.12M
25.45%-11.33M
-6.19%-3.41M
38.42%-2.07M
42.88%-2.42M
21.87%-3.43M
-0.78%-15.2M
-1.13%-3.21M
Basic earnings per share
64.71%-0.54
37.69%-1.24
40.00%-1.8
49.09%-8.4
36.36%-2.1
57.50%-1.53
57.20%-1.99
39.39%-3
5.17%-16.5
8.33%-3.3
Diluted earnings per share
64.71%-0.54
37.69%-1.24
40.00%-1.8
49.09%-8.4
36.36%-2.1
57.50%-1.53
57.20%-1.99
39.39%-3
5.17%-16.5
8.33%-3.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 2.37%4.23M-58.44%2.06M-10.14%3.38M-1.94%17.93M5.01%5.09M-10.38%4.13M5.25%4.95M-8.88%3.76M41.57%18.28M36.50%4.85M
Operating revenue 2.37%4.23M-58.66%1.98M-10.14%3.38M-5.30%16.97M-7.84%4.14M-10.38%4.13M4.35%4.8M-8.88%3.76M50.35%17.92M75.45%4.49M
Cost of revenue -12.60%1.68M-46.48%1.24M-13.07%1.57M-8.54%8.41M-4.12%2.38M-10.74%1.92M-5.55%2.31M-14.94%1.81M37.35%9.2M32.30%2.48M
Gross profit 15.39%2.55M-68.94%819K-7.43%1.81M4.76%9.51M14.56%2.71M-10.06%2.21M16.99%2.64M-2.45%1.95M46.11%9.08M41.18%2.37M
Operating expense -18.50%3.95M-3.58%4.79M0.75%5.25M-17.44%19.97M-15.02%4.94M-10.01%4.85M-23.95%4.97M-19.25%5.21M11.12%24.19M-4.84%5.82M
Selling and administrative expenses -16.46%3.4M2.23%3.94M4.59%4.26M-16.01%16.1M-9.01%4.1M-3.71%4.07M-24.98%3.86M-23.10%4.07M5.63%19.17M-12.83%4.51M
-Selling and marketing expense -25.40%1.31M-8.45%1.69M-6.11%1.71M-13.74%7.31M-4.99%1.88M-14.23%1.76M-21.41%1.85M-12.93%1.82M18.37%8.47M1.95%1.98M
-General and administrative expense -9.65%2.09M12.04%2.25M13.23%2.55M-17.81%8.79M-12.17%2.22M6.20%2.31M-27.98%2.01M-29.73%2.25M-2.67%10.69M-21.75%2.52M
Research and development costs -29.21%550K-23.66%852K-13.03%988K-22.91%3.87M-35.64%845K-32.96%777K-20.17%1.12M-1.56%1.14M38.58%5.03M38.79%1.31M
Operating profit 46.87%-1.4M-70.24%-3.98M-5.65%-3.44M30.78%-10.46M35.34%-2.23M9.96%-2.64M45.49%-2.34M26.80%-3.26M2.85%-15.11M22.25%-3.45M
Net non-operating interest income expense 77.22%-18K12.16%-65K-26.32%-72K10.93%-269K10.61%-59K-23.44%-79K-21.31%-74K49.11%-57K-93.59%-302K0.00%-66K
Non-operating interest expense -77.22%18K-12.16%65K26.32%72K-10.93%269K-10.61%59K23.44%79K21.31%74K-49.11%57K93.59%302K0.00%66K
Other net income (expense) -100.15%-1K19,114.29%1.33M635.34%621K-378.24%-601K-473.42%-1.12M274.59%646K-106.09%-7K-167.84%-116K-65.82%216K-77.27%301K
Gain on sale of security -99.38%4K19,228.57%1.34M640.52%627K-315.05%-600K-456.01%-1.13M273.73%648K-104.83%-7K-160.73%-116K-57.85%279K-76.68%316K
Other non- operating income (expenses) -150.00%-5K---8K---6K98.41%-1K106.67%1K-166.67%-2K---------110.00%-63K51.61%-15K
Income before tax 31.42%-1.42M-12.13%-2.71M15.69%-2.89M25.45%-11.33M-6.19%-3.41M38.42%-2.07M42.88%-2.42M21.87%-3.43M-0.78%-15.2M-1.13%-3.21M
Income tax
Net income 31.42%-1.42M-12.13%-2.71M15.69%-2.89M25.45%-11.33M-6.19%-3.41M38.42%-2.07M42.88%-2.42M21.87%-3.43M-0.78%-15.2M-1.13%-3.21M
Net income continuous Operations 31.42%-1.42M-12.13%-2.71M15.69%-2.89M25.45%-11.33M-6.19%-3.41M38.42%-2.07M42.88%-2.42M21.87%-3.43M-0.78%-15.2M-1.13%-3.21M
Minority interest income
Net income attributable to the parent company 31.42%-1.42M-12.13%-2.71M15.69%-2.89M25.45%-11.33M-6.19%-3.41M38.42%-2.07M42.88%-2.42M21.87%-3.43M-0.78%-15.2M-1.13%-3.21M
Preferred stock dividends
Other preferred stock dividends 226K0
Net income attributable to common stockholders 31.42%-1.42M-12.13%-2.71M9.10%-3.12M25.45%-11.33M-6.19%-3.41M38.42%-2.07M42.88%-2.42M21.87%-3.43M-0.78%-15.2M-1.13%-3.21M
Basic earnings per share 64.71%-0.5437.69%-1.2440.00%-1.849.09%-8.436.36%-2.157.50%-1.5357.20%-1.9939.39%-35.17%-16.58.33%-3.3
Diluted earnings per share 64.71%-0.5437.69%-1.2440.00%-1.849.09%-8.436.36%-2.157.50%-1.5357.20%-1.9939.39%-35.17%-16.58.33%-3.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More